NEXAVAR vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. NEXAVAR and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NEXAVAR	SIROLIMUS
Rating	New	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	SORAFENIB TOSYLATE	SIROLIMUS
Manufacturer	Bayer Hlthcare	Apotex
Dosage forms	Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

nexavar sirolimus

Rating

New

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

SORAFENIB TOSYLATE

SIROLIMUS

Manufacturer

Bayer Hlthcare

Apotex

Dosage forms

Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Nexavar and Sirolimus?

Nexavar contains Sorafenib Tosylate, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.